Skip to main content

Featured

Trade Tensions Rattle Wall Street’s Momentum

After an impressive streak of gains that pushed major U.S. indices to record highs, the stock market faced a sharp reversal as renewed trade tensions triggered investor anxiety. The Dow Jones Industrial Average, S&P 500, and Nasdaq all pulled back in Friday’s session, with financials and industrials leading the retreat. Concerns were reignited after new tariffs targeting tech and manufacturing imports between the U.S. and China surfaced, prompting fears of escalating economic friction. These measures, aimed at protecting domestic industries, were met with criticism from global partners and stoked uncertainty about the broader trade landscape. Analysts note that while earnings remain strong and economic indicators are still resilient, the shadow of protectionism looms large. Investor sentiment, which had been buoyed by dovish monetary policy and solid corporate results, now finds itself caught in geopolitical crosswinds. Many traders are now recalibrating their expectations heading ...

article

Drug shortages in Canada affect millions of patients and health care providers

 

  

Many Canadians have experienced the frustration and anxiety of not being able to get the medications they need, as the country faces a persistent and worsening problem of drug shortages.

According to a survey commissioned by the Canadian Pharmacists Association, one in four adults in Canada has either personally been affected by drug shortages in the last three years or knows someone who has. The survey also found that 70% of pharmacists have difficulty finding alternative drugs for their patients.

The causes of drug shortages are complex and varied, ranging from manufacturing issues, supply chain disruptions, regulatory hurdles, market decisions by pharmaceutical companies, and increased demand for certain drugs due to the COVID-19 pandemic.

Some of the drugs that have been in short supply include Lenoltec No. 4, a painkiller containing codeine; Ozempic, a widely-used drug for type 2 diabetes; EpiPens, which are essential for people with life-threatening allergies; Wellbutrin, a popular antidepressant; and various blood pressure medications.

Drug shortages can have serious consequences for patients and health care providers, such as increased costs, reduced quality of care, delayed or cancelled treatments, adverse reactions, medication errors, and psychological distress.

Health Canada has said it is aware of the issue and working to find solutions, such as facilitating the importation of foreign drugs, monitoring the supply situation, and collaborating with stakeholders. However, some experts have called for more action, such as investing in domestic production capacity, creating a national drug agency, and implementing mandatory reporting of drug shortages by manufacturers.

Comments